Impact of COVID-19 Pandemic on Patients with Serious Mental Illness (SMI) and Nonpsychiatric Control Subjects in Clinical Trials
by Maria Fe Garcia-Rada, MPS, and Robert E. Litman, MD [...]
Current and Emerging Technologies to Address the Placebo Response Challenge in CNS Clinical Trials: Promise, Pitfalls, and Pathways Forward
by William P. Horan, PhD; Gary Sachs, MD; Dawn I. [...]
Ensuring Stakeholder Feedback in the Design and Conduct of Clinical Trials for Rare Diseases: ISCTM Position Paper of the Orphan Disease Working Group
by Gahan J. Pandina, PhD; Joan Busner, PhD; Lucas Kempf, [...]
WORDS: A New Verbal Memory Test to Evaluate Cognitive Health in a Zambian School-aged Population
by Franco Di Cesare, MD; Giulia Piccinini, MD; Cristiana Di [...]
Innovative Technologies in CNS Trials: Promises and Pitfalls for Recruitment, Retention, and Representativeness
by Jacqueline Lutz, PhD; Abhishek Pratap, PhD; Eric J. Lenze, [...]
WAVES: A Novel Test to Evaluate Visuospatial Construction Ability in a School-aged Population
by Franco Di Cesare, MD; Cristiana Di Carlo, MSc; and Leonardo [...]
Development of a Symbol Cancellation Test to Evaluate Attention in a School-aged Zambian Population
by Franco Di Cesare, MD; Cristiana Di Carlo, MSc; and Leonardo [...]
Impact of COVID-19 Pandemic on Psychiatric Patients at Clinical Trial Sites
by Maria Fe Garcia-Rada, MPS, and Robert E. Litman, MD [...]
CNS Summit 2022 Abstracts of Poster Presentations
A message from the editor Dear Colleagues: Welcome to the [...]
Implementing Digital Technologies in Clinical Trials: Lessons Learned
by Georgia Mitsi, PhD; Todd Grinnell, BA; Suzanne Giordano, PhD; [...]